2023 Q2 Form 10-Q Financial Statement

#000151470523000008 Filed on May 04, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $534.4M $487.8M
YoY Change 6.48% 10.91%
Cost Of Revenue $443.1M $402.0M
YoY Change 7.6% 18.93%
Gross Profit $91.30M $85.80M
YoY Change 1.33% -15.72%
Gross Profit Margin 17.08% 17.59%
Selling, General & Admin $17.40M $18.80M
YoY Change -12.12% 4.44%
% of Gross Profit 19.06% 21.91%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $36.40M $35.30M
YoY Change 1.68% 0.28%
% of Gross Profit 39.87% 41.14%
Operating Expenses $53.80M $18.80M
YoY Change 171.72% 4.44%
Operating Profit $37.50M $31.70M
YoY Change 8.7% -34.77%
Interest Expense -$7.200M $7.200M
YoY Change -186.75% -10.0%
% of Operating Profit -19.2% 22.71%
Other Income/Expense, Net
YoY Change
Pretax Income $30.30M $24.50M
YoY Change 15.65% -39.66%
Income Tax $8.300M $6.800M
% Of Pretax Income 27.39% 27.76%
Net Earnings $20.40M $16.30M
YoY Change 13.33% -44.75%
Net Earnings / Revenue 3.82% 3.34%
Basic Earnings Per Share $0.24 $0.19
Diluted Earnings Per Share $0.24 $0.19
COMMON SHARES
Basic Shares Outstanding 83.72M shares 83.41M shares
Diluted Shares Outstanding 84.90M shares 84.90M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $78.20M $83.30M
YoY Change 23.34% 4.52%
Cash & Equivalents $78.20M $83.30M
Short-Term Investments
Other Short-Term Assets $7.300M $10.50M
YoY Change 10.61% 5.0%
Inventory $200.4M $234.8M
Prepaid Expenses
Receivables $96.90M $81.20M
Other Receivables $0.00 $0.00
Total Short-Term Assets $382.8M $409.8M
YoY Change 3.13% 6.91%
LONG-TERM ASSETS
Property, Plant & Equipment $1.208B $1.208B
YoY Change -3.6% -4.6%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $20.10M $19.00M
YoY Change 8.65% -12.04%
Total Long-Term Assets $1.261B $1.260B
YoY Change -3.49% -4.76%
TOTAL ASSETS
Total Short-Term Assets $382.8M $409.8M
Total Long-Term Assets $1.261B $1.260B
Total Assets $1.643B $1.669B
YoY Change -2.03% -2.13%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $173.9M $172.7M
YoY Change 9.1% 2.74%
Accrued Expenses $41.50M $45.60M
YoY Change -19.57% -6.75%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.400M $3.400M
YoY Change 6.25% 6.25%
Total Short-Term Liabilities $222.5M $231.8M
YoY Change 3.2% 0.7%
LONG-TERM LIABILITIES
Long-Term Debt $493.0M $528.4M
YoY Change -17.09% -15.46%
Other Long-Term Liabilities $107.1M $23.50M
YoY Change 378.13% 4.91%
Total Long-Term Liabilities $600.1M $551.9M
YoY Change -2.74% -14.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $222.5M $231.8M
Total Long-Term Liabilities $600.1M $551.9M
Total Liabilities $1.034B $1.041B
YoY Change -6.24% -8.99%
SHAREHOLDERS EQUITY
Retained Earnings $76.50M $63.00M
YoY Change 450.36% 6200.0%
Common Stock $1.000M $1.000M
YoY Change 0.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $609.0M $593.5M
YoY Change
Total Liabilities & Shareholders Equity $1.643B $1.669B
YoY Change -2.03% -2.13%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income $20.40M $16.30M
YoY Change 13.33% -44.75%
Depreciation, Depletion And Amortization $36.40M $35.30M
YoY Change 1.68% 0.28%
Cash From Operating Activities $68.70M $30.20M
YoY Change 57.93% 33.04%
INVESTING ACTIVITIES
Capital Expenditures $27.80M $22.60M
YoY Change 31.75% 75.19%
Acquisitions
YoY Change
Other Investing Activities $100.0K -$300.0K
YoY Change -400.0%
Cash From Investing Activities -$27.70M -$22.30M
YoY Change 31.9% 71.54%
FINANCING ACTIVITIES
Cash Dividend Paid $6.700M
YoY Change 34.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -46.10M -$14.60M
YoY Change 18.81% -335.48%
NET CHANGE
Cash From Operating Activities 68.70M $30.20M
Cash From Investing Activities -27.70M -$22.30M
Cash From Financing Activities -46.10M -$14.60M
Net Change In Cash -5.100M -$6.700M
YoY Change -68.71% -142.14%
FREE CASH FLOW
Cash From Operating Activities $68.70M $30.20M
Capital Expenditures $27.80M $22.60M
Free Cash Flow $40.90M $7.600M
YoY Change 82.59% -22.45%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
3 segment
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001514705
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-35243
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
SUNCOKE ENERGY, INC.
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-0640593
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
1011 Warrenville Road
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 600
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Lisle
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60532
CY2023Q1 dei City Area Code
CityAreaCode
630
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
824-1000
CY2023Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01 per share
CY2023Q1 dei Trading Symbol
TradingSymbol
SXC
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
83720154 shares
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
487800000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
439800000 usd
CY2023Q1 sxc Cost Of Goods Sold And Operating Expenses
CostOfGoodsSoldAndOperatingExpenses
402000000.0 usd
CY2022Q1 sxc Cost Of Goods Sold And Operating Expenses
CostOfGoodsSoldAndOperatingExpenses
338000000.0 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18800000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18000000.0 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
35300000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
35200000 usd
CY2023Q1 us-gaap Costs And Expenses
CostsAndExpenses
456100000 usd
CY2022Q1 us-gaap Costs And Expenses
CostsAndExpenses
391200000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
31700000 usd
CY2022Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
48600000 usd
CY2023Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7200000 usd
CY2022Q1 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-8000000.0 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24500000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
40600000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6800000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000000.0 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
17700000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
30600000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1400000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1100000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
16300000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
29500000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.19
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.35
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.19
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.35
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84500000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83200000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84900000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84200000 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
17700000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
30600000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
100000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Amortization Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Prior Service Cost Credit Net Of Tax
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditNetOfTax
100000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
100000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1300000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
17900000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
32000000.0 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1400000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
1100000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
16500000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
30900000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
83300000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
90000000.0 usd
CY2023Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81200000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
104800000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
234800000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
175200000 usd
CY2023Q1 us-gaap Other Assets Current
OtherAssetsCurrent
10500000 usd
CY2022Q4 us-gaap Other Assets Current
OtherAssetsCurrent
4000000.0 usd
CY2023Q1 us-gaap Assets Current
AssetsCurrent
409800000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
374000000.0 usd
CY2023Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1310300000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1276000000 usd
CY2023Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1207800000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1229300000 usd
CY2023Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
32700000 usd
CY2022Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
33200000 usd
CY2023Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
19000000.0 usd
CY2022Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
18100000 usd
CY2023Q1 us-gaap Assets
Assets
1669300000 usd
CY2022Q4 us-gaap Assets
Assets
1654600000 usd
CY2023Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
172700000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
159300000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45600000 usd
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60800000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
3400000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3300000 usd
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
6100000 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0 usd
CY2023Q1 us-gaap Taxes Payable Current
TaxesPayableCurrent
4000000.0 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
600000 usd
CY2023Q1 us-gaap Liabilities Current
LiabilitiesCurrent
231800000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
224000000.0 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
528400000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
528900000 usd
CY2023Q1 sxc Accrual For Black Lung Benefits
AccrualForBlackLungBenefits
52700000 usd
CY2022Q4 sxc Accrual For Black Lung Benefits
AccrualForBlackLungBenefits
52200000 usd
CY2023Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
15900000 usd
CY2022Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
16400000 usd
CY2023Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
175100000 usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
172300000 usd
CY2023Q1 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
13600000 usd
CY2022Q4 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
13400000 usd
CY2023Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
23500000 usd
CY2022Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
24700000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
1041000000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
1031900000 usd
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
99124637 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
98815780 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
1000000.0 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000000.0 usd
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15404482 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
15404482 shares
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
184000000.0 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
184000000.0 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
726300000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
728100000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12800000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13000000.0 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
63000000.0 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
53500000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
593500000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
585600000 usd
CY2023Q1 us-gaap Minority Interest
MinorityInterest
34800000 usd
CY2022Q4 us-gaap Minority Interest
MinorityInterest
37100000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
628300000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
622700000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1669300000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1654600000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
17700000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
30600000 usd
CY2023Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
35300000 usd
CY2022Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
35200000 usd
CY2023Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
2800000 usd
CY2022Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5300000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1600000 usd
CY2022Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1100000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-23300000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
21900000 usd
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
59000000.0 usd
CY2022Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
66900000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
22200000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
41900000 usd
CY2023Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-15300000 usd
CY2022Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3900000 usd
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
6100000 usd
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
6100000 usd
CY2023Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-3400000 usd
CY2022Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-3300000 usd
CY2023Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-7900000 usd
CY2022Q1 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
-8100000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
30200000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22700000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22600000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12900000 usd
CY2023Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-300000 usd
CY2022Q1 us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
100000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-22300000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13000000.0 usd
CY2023Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
139000000.0 usd
CY2022Q1 us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
137000000.0 usd
CY2023Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
139000000.0 usd
CY2022Q1 us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
122000000.0 usd
CY2023Q1 sxc Repaymentsof Sale Leaseback Financing Obligation
RepaymentsofSaleLeasebackFinancingObligation
800000 usd
CY2022Q1 sxc Repaymentsof Sale Leaseback Financing Obligation
RepaymentsofSaleLeasebackFinancingObligation
800000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
6700000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
5000000.0 usd
CY2023Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
3700000 usd
CY2022Q1 us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
1500000 usd
CY2023Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3400000 usd
CY2022Q1 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1500000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14600000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
6200000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6700000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
15900000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90000000.0 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
63800000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
83300000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
79700000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
500000 usd
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
900000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
500000 usd
CY2022Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1400000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
622700000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
17700000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-100000 usd
CY2023Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
100000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1600000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-3400000 usd
CY2023Q1 us-gaap Dividends
Dividends
6800000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
3700000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
628300000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
535400000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
30600000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-100000 usd
CY2022Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax
1300000 usd
CY2022Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2500000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
-1400000 usd
CY2022Q1 us-gaap Dividends
Dividends
5100000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
1500000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
561900000 usd
CY2023Q1 sxc Coke Production Experience
CokeProductionExperience
P60Y
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60800000 usd
CY2023Q1 us-gaap Energy Related Inventory Coal
EnergyRelatedInventoryCoal
145700000 usd
CY2022Q4 us-gaap Energy Related Inventory Coal
EnergyRelatedInventoryCoal
109400000 usd
CY2023Q1 sxc Inventory Coke
InventoryCoke
34500000 usd
CY2022Q4 sxc Inventory Coke
InventoryCoke
14300000 usd
CY2023Q1 sxc Inventory Materials Supplies And Other
InventoryMaterialsSuppliesAndOther
54600000 usd
CY2022Q4 sxc Inventory Materials Supplies And Other
InventoryMaterialsSuppliesAndOther
51500000 usd
CY2023Q1 us-gaap Inventory Net
InventoryNet
234800000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
175200000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
439800000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
40000000.0 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10700000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
29300000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
40000000.0 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
10200000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
29800000 usd
CY2022Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
500000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
487800000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
24500000 usd
CY2022Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
40600000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6800000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000000.0 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.278
CY2022Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.246
CY2023Q1 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
0 usd
CY2022Q1 us-gaap Income Tax Reconciliation Change In Enacted Tax Rate
IncomeTaxReconciliationChangeInEnactedTaxRate
-1000000 usd
CY2023Q1 sxc Effective Income Tax Rate Reconciliation Percent Before Impact Of Discrete Items
EffectiveIncomeTaxRateReconciliationPercentBeforeImpactOfDiscreteItems
27.8
CY2022Q1 sxc Effective Income Tax Rate Reconciliation Percent Before Impact Of Discrete Items
EffectiveIncomeTaxRateReconciliationPercentBeforeImpactOfDiscreteItems
27.2
CY2023Q1 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
13400000 usd
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
29700000 usd
CY2023Q1 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent
2400000 usd
CY2022Q4 us-gaap Pension And Other Postretirement And Postemployment Benefit Plans Liabilities Current
PensionAndOtherPostretirementAndPostemploymentBenefitPlansLiabilitiesCurrent
2400000 usd
CY2023Q1 sxc Accrued Other Taxes Payable
AccruedOtherTaxesPayable
12100000 usd
CY2022Q4 sxc Accrued Other Taxes Payable
AccruedOtherTaxesPayable
9800000 usd
CY2023Q1 sxc Current Portion Of Black Lung Liability
CurrentPortionOfBlackLungLiability
5900000 usd
CY2022Q4 sxc Current Portion Of Black Lung Liability
CurrentPortionOfBlackLungLiability
5900000 usd
CY2023Q1 sxc Accrued Legal Costs Current
AccruedLegalCostsCurrent
5200000 usd
CY2022Q4 sxc Accrued Legal Costs Current
AccruedLegalCostsCurrent
4900000 usd
CY2023Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
6600000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
8100000 usd
CY2023Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
45600000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
543000000.0 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
543800000 usd
CY2023Q1 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
11200000 usd
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
11600000 usd
CY2023Q1 us-gaap Long Term Debt
LongTermDebt
531800000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
532200000 usd
CY2023Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
3400000 usd
CY2022Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
3300000 usd
CY2023Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
528400000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
528900000 usd
CY2023Q1 sxc Threshold For Disclosing Material Environmental Legal Proceedings
ThresholdForDisclosingMaterialEnvironmentalLegalProceedings
1000000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84500000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83200000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
400000 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1000000.0 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84900000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84200000 shares
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
439800000 usd
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1400000 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1800000 shares
CY2023Q1 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
482300000 usd
CY2022Q4 us-gaap Long Term Debt Fair Value
LongTermDebtFairValue
471900000 usd
CY2023Q1 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
543000000 usd
CY2022Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
543800000 usd
CY2023Q1 sxc Number Of Performance Obligations In Handling And Mixing Services
NumberOfPerformanceObligationsInHandlingAndMixingServices
2 performanceobligation
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
487800000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
487800000 usd
CY2022Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
439800000 usd
CY2023Q1 sxc Adjusted Ebitda
AdjustedEBITDA
67100000 usd
CY2022Q1 sxc Adjusted Ebitda
AdjustedEBITDA
83800000 usd
CY2023Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
35300000 usd
CY2022Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
35200000 usd
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
22600000 usd
CY2022Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
12900000 usd
CY2023Q1 us-gaap Assets
Assets
1669300000 usd
CY2022Q4 us-gaap Assets
Assets
1654600000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
16300000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
29500000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1400000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1100000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
17700000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
30600000 usd
CY2023Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
35300000 usd
CY2022Q1 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
35200000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
7200000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
8000000.0 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
6800000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
10000000.0 usd
CY2023Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
100000 usd
CY2022Q1 us-gaap Business Combination Acquisition Related Costs
BusinessCombinationAcquisitionRelatedCosts
0 usd
CY2023Q1 sxc Adjusted Ebitda
AdjustedEBITDA
67100000 usd
CY2022Q1 sxc Adjusted Ebitda
AdjustedEBITDA
83800000 usd
CY2023Q1 sxc Adjusted Ebitda Portion Attributableto Noncontrolling Interests
AdjustedEBITDAPortionAttributabletoNoncontrollingInterests
2500000 usd
CY2022Q1 sxc Adjusted Ebitda Portion Attributableto Noncontrolling Interests
AdjustedEBITDAPortionAttributabletoNoncontrollingInterests
2100000 usd
CY2023Q1 sxc Adjusted Ebitda Excluding Portion Attributableto Noncontrolling Interests
AdjustedEBITDAExcludingPortionAttributabletoNoncontrollingInterests
64600000 usd
CY2022Q1 sxc Adjusted Ebitda Excluding Portion Attributableto Noncontrolling Interests
AdjustedEBITDAExcludingPortionAttributabletoNoncontrollingInterests
81700000 usd

Files In Submission

Name View Source Status
0001514705-23-000008-index-headers.html Edgar Link pending
0001514705-23-000008-index.html Edgar Link pending
0001514705-23-000008.txt Edgar Link pending
0001514705-23-000008-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
sxc-20230331.htm Edgar Link pending
sxc-20230331.xsd Edgar Link pending
sxcex22110-q2023q1.htm Edgar Link pending
sxcex31110-q2023q1.htm Edgar Link pending
sxcex31210-q2023q1.htm Edgar Link pending
sxcex32110-q2023q1.htm Edgar Link pending
sxcex32210-q2023q1.htm Edgar Link pending
sxcex95110-q2023q1.htm Edgar Link pending
sxc-20230331_cal.xml Edgar Link unprocessable
sxc-20230331_pre.xml Edgar Link unprocessable
sxc-20230331_lab.xml Edgar Link unprocessable
sxc-20230331_def.xml Edgar Link unprocessable
sxc-20230331_htm.xml Edgar Link completed